Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-17 00:00:00 ET · period of report 2021-08-16 · accession 0001237899-21-000016 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-08-17 | 2021-08-16 | REGN | SING GEORGE L | Dir | S - Sale | $627.50 | -1,000 | 2,050 | -33% | -$627.5K |
| 2021-08-17 | 2021-08-16 | REGN | SING GEORGE L | Dir | S - Sale | $630.00 | -705 | 43.9K | -2% | -$444.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-16 | S | D | 1,000 | $627.50 | 2,050 | I | — | — | (F1) Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 16, 2021 at prices ranging from $627.37 to $627.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 16, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-08-16 | S | D | 705 | $630.00 | 43,858 | D by Trust for Son | — | — |